Breast Cancer Clinical Trials in Massachusetts

Showing 461-480 of 511 trials

Hypertension in Breast Cancer Patients Receiving Bevacizumab

NCT00674011

This research study will look at the effect of an anti-angiogenesis medication called Bevacizumab on blood vessels. Anti-angiogenesis medicines fight cancer by cutting off a tumor's blood supply, starving the tumor of nutrients and oxygen. Previous studies have shown these types of drugs can cause hypertension. The purpose of this study is to help researchers better understand why these drugs cause hypertension. This information will assist researchers in learning how to control this side effect.

Breast Cancer

Dana-Farber Cancer Institute10 participantsStarted Jan 2008

Boston, Massachusetts, United States

COMPLETEDPhase 226 miles

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

NCT00450866

RATIONALE: Drugs used in chemotherapy, such as epothilone B, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well epothilone B works in treating patients with CNS metastases from breast cancer.

Breast CancerMetastatic Cancer

David Peereboom, MD55 participantsStarted Jan 2007

Boston, Massachusetts, United States • Ann Arbor, Michigan, United States • New York, New York, United States +2 more locations

TERMINATEDPhase 126 miles

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

NCT00071942

Vaccines may make the body build an immune response to kill tumor cells. This phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with metastatic breast cancer.

Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer

National Cancer Institute (NCI)22 participantsStarted Oct 2003

Boston, Massachusetts, United States

Hypertension in Breast Cancer Patients Receiving Bevacizumab

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer

Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

Nutrition Intervention in Treating Women With Breast Cancer

Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

Other Conditions in Massachusetts